Using the immune system to fight cancer

From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes

STEM – inspiring tomorrow’s science and engineering superstars

Meet this year’s GSK UK Young Scientist and Engineers of the Year.

We need more women in science to create the inclusive technologies of the future

To mark International Day of Women and Girls in Science, Nidhi Aggarwal, Global Packaging Development Manager in our Consumer Healthcare business, tells how she reached her current role and explains why we need more diversity of thought in science and applied fields.

COPD is more than a lung disease

Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing.

Using the immune system to fight cancer

A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.

From bench to bedside: lessons in converting science into impact

How a chance encounter led to a world-first toothpaste

TB: uniting scientists to tackle one of the world’s biggest killers

Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease.

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

The vaccines of tomorrow

Join our leading scientists as they go behind the science of vaccine technology.

You, me and 23andMe: discovering new medicines through genetics

Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow.

Overcoming obstacles to end malaria

The little pill that could: one medicine taking on two neglected diseases

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

Complete the cycle – how we’re recycling inhalers

When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.

Fighting malaria in the lab and on the ground

Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products.

How genomics is driving a new era of drug discovery

How are we redefining research in HIV?

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Meet John - at 80 years old, he refuses to let COPD get in the way of living the life he wants to.

Making the Ellipta® inhaler a reality

The story behind the device now used by millions of people globally

Overcoming the challenges of COPD to fulfil a lifelong dream

Making sense of what consumers want

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breaking through the pain barrier: our latest research

From a passing headache to chronic back pain, we are working hard to better understand why we experience pain and develop more effective pain relief treatments.

I control my asthma, it doesn’t control me

Jamie from our Montrose site tells how he managed his asthma to conquer Mount Kenya

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.

You'll outgrow some childhood habits, but vaccination is for life

How curious minds saved a medicine from being left in the lab

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

From TV to tackling lupus: why Alex moved from media to medicine

Alex Liakos on becoming a lupus medic, and listening to the patient

Giving a bit back – Christine’s experience of clinical research

For Christine even gentle exercise like jogging and walking her dogs around the park were a struggle. She just could not breathe properly.

The race against malaria: handing the baton to the next generation

Malaria is a preventable and treatable disease yet it still claims hundreds of thousands of lives each year, mostly in children under five.

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Setting the record straight: Why we publish data both positive and negative

Making the switch: how we’re improving access to proven medicines

Switching a medicine from prescription to over-the-counter places the power of managing everyday health conditions with the patient.

Supporting community health across the UK

Our GSK IMPACT Awards have been rewarding community health and wellbeing charities for the past 20 years.

30 years and counting: the fight against HIV

How to find a treatment for a disease with no idea what that disease actually is.

HIV research focus on finding a cure

With 34 million people around the world living with HIV/AIDS, preventing and treating HIV infection remains an enormous global challenge.

What are Bioelectronics

Live every breath

Vaccines: the most successful health intervention… ever

Vaccines for preventable diseases

Joining forces to fight malaria

We’ve been fighting against malaria for the past 100 years and now we’ve joined forces with Comic Relief.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

Taking action to stop pneumonia

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Maternal immunisation: Helping protect mums and babies

Immunisation during pregnancy can help protect the mother, and also help protect the baby before birth and through the critical first few weeks of life.

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Tackling tomorrow’s health challenges today

Don’t forget the pharmacists

Rabies – Educate, Vaccinate, Eliminate.

28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’.

Partnership for Prevention

Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Collaboration: unlocking a new approach to clinical trials

The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.

Helping to change the world

A new response to humanitarian crises

A partnership that is all about the chemistry

See how our trainer trains sub Saharan Africa scientists in analytical chemistry.

Can an iPhone transform the way we monitor and improve patient health?

We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Inhaler innovation: more than a simple piece of plastic

From microscope to telescope and beyond – exploring with NASA's CASIS

Meet Baby Mckline: a special delivery from our Save the Children partnership

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

Turning the tide on antibiotic resistance

Guardian article: The 30-year quest for a malaria vaccine

Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

The power of partnerships: transforming vaccine coverage in Mozambique

The value of vaccination

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Take a deep breath – your lung microbiome will appreciate it

Helping to further science and research – Howard’s perspective

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

Delivering support for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

School leading the way to inspire young scientists

Dr Louise Morris wants every student at her school to have the education and opportunity to have a career in STEM.

Harnessing the electrical language of the body to treat disease

Telegraph article: Science hasn't answered all the questions on HIV

Igniting a revolution in scientific research and development

How can partnerships between science, business and charities help tackle some of the world's most challenging healthcare issues?

Guardian article: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Guardian article: A different way of doing business to support Kenyan mothers

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Turning waste into a resource

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Experimental medicine

Outgrowing asthma

TEDMED 2015: An interview with curator, Christine McNab

We interview Christine McNab, curator of The Art of Saving a Life.

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

TEDMED 2015: Art, inspired by vaccination

A blank canvas, Unformed clay. An empty petri dish.

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Less is more with advanced technologies in manufacturing

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

To challenge. To change.

At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer.

Health workers fighting it on the frontline

No 'silver bullet' to tackle this disease

On the frontline of Ebola prevention

Read how Robbie worked on the ground to fight Ebola.

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?

Making our vaccines more accessible

Vaccines - coming in from the cold

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Fighting Ebola highlights the need for more health workers

The Ebola crisis is by far the worst outbreak of the disease the world has ever seen.

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Why our transaction with Novartis is different

Ebola vaccine R&D

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Our humanitarian response to the Ebola outbreak

GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries.

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

Flonase: the journey from prescription to OTC

Africa’s fight against malaria: how mothers are helping on the ground

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Neuroscience: on the brain

The 'baby bubble'

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Life after polio: Fatiha's story